Iovance Biotherapeutics: ASCO Update, Competitor Data And The Road Ahead
Source: SeekingAlpha
2025-07-02 09:35:55 ET
...
Read the full article on Seeking Alpha
For further details see:
Iovance Biotherapeutics: ASCO Update, Competitor Data And The Road Ahead
Replimune Group Inc.
NASDAQ: REPL
REPL Trading
5.82% G/L:
$4.92 Last:
468,034 Volume:
$4.90 Open:
REPL Latest News
REPL Stock Data
$646,543,607
51,607,887
0.33%
61
N/A
Biotechnology & Life Sciences
Healthcare
US
Woburn
